XML 308 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
Property, plant and equipment, net
 12 Months Ended
Dec. 31, 2024
Property Plant and Equipment Income Statement Disclosures [Abstract]  
Property, plant and equipment, net Property, plant and equipment, net
Property, plant and equipment, net consists of the following:
 
December 31,
2024 (1)
2023 (1)
Land and improvements$25.8 $30.0 
Buildings, building improvements and leasehold improvements196.1 229.9 
Furniture and equipment368.3 433.6 
Software67.2 64.0 
Construction-in-progress10.3 36.7 
Property, plant and equipment, gross$667.7 $794.2 
Less: Accumulated depreciation and amortization(397.1)(411.4)
Total property, plant and equipment, net$270.6 $382.8 
(1) During the years ended December 31, 2024 and 2023, the Company recorded non-cash impairment charges of $27.2 million and $306.7 million, respectively, related to certain Bioservices long-lived assets. See Note 4, “Impairment and restructuring charges” for more details regarding the impairment charge.
For the years ended December 31, 2024 and 2023, construction-in-progress primarily included costs incurred to advance the Company's MCM Product capabilities.
Property, plant and equipment, net is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization expense associated with property, plant and equipment was $43.7 million, $59.5 million and $83.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. During the year ended December 31, 2022, the Company recorded accelerated depreciation of $12.7 million reflecting a shortening of the useful life of certain property, plant and equipment which were to be used in the manufacturing process to fulfill the Janssen Agreement. For additional information related to the termination of the Janssen Agreement, refer to Note 19, “Litigation”.